VLON insider filings

Vallon Pharmaceuticals, Inc. — 20 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-12-15. Screen VLON transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for VLON between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Vallon Pharmaceuticals, Inc.

FiledFormInsiderReported transactionsSource
2022-12-154Thorell Marella — DirectorOther (J): 28,517 @ $0EDGAR
2022-07-064Thorell Marella — DirectorGrant/award (A): 38,023 @ $0EDGAR
2022-06-104Ammer Richard — DirectorGrant/award (A): 7,500 (derivative) @ $0EDGAR
2022-06-104Thorell Marella — DirectorGrant/award (A): 7,500 (derivative) @ $0EDGAR
2022-06-104Payne Joseph E — DirectorGrant/award (A): 7,500 (derivative) @ $0EDGAR
2022-03-094Chhabra Meenu — DirectorGrant/award (A): 15,000 (derivative) @ $7.67EDGAR
2022-03-014Baker David Charles — Chief Executive Officer, DirectorGrant/award (A): 61,000 (derivative) @ $5.63EDGAR
2022-03-014Kelly Leanne M. — Chief Financial OfficerGrant/award (A): 50,000 (derivative) @ $5.63EDGAR
2021-06-044Kelly Leanne M. — Chief Financial OfficerPurchase (P): 3,657 @ $4 · Purchase (P): 1,085 @ $4.05 · Purchase (P): 1,508 @ $4.08EDGAR
2021-05-274Payne Joseph E — DirectorPurchase (P): 10,700 @ $3.85 · Purchase (P): 6,800 @ $4.50EDGAR
2021-05-184Baker David Charles — Chief Executive Officer, DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2021-05-184Ammer Richard — DirectorGrant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 10,204 (derivative) @ $0EDGAR
2021-05-184Levi Ofir — DirectorGrant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0EDGAR
2021-05-184Toren Penny — SVP, Regul Affairs & Prog MgmtGrant/award (A): 25,000 (derivative) @ $0EDGAR
2021-05-184Payne Joseph E — DirectorGrant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 14,286 (derivative) @ $0EDGAR
2021-05-184Kelly Leanne M. — Chief Financial OfficerGrant/award (A): 70,000 (derivative) @ $0EDGAR
2021-02-124Ammer Richard — DirectorOther (J): 47,063 @ $6.40EDGAR
2021-02-124SALMON Pharma GmbH — 10% ownerOther (J): 47,063 @ $6.40EDGAR
2021-02-124Thorell Marella — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2021-02-124Baker David Charles — Chief Executive Officer, DirectorOther (J): 7,843 @ $6.40 · Purchase (P): 1,000 @ $8EDGAR

Recent 8-K events — Vallon Pharmaceuticals, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-048-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-088-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-188-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-148-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-048-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-308-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-288-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-218-K3.03 — Material Modification to Rights of Security Holders
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-168-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2026-01-158-K5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=VLON returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs